COVID-19 Vaccines Emerging Issues: Delayed Injection Site Reactions
Organization: Public Health Agency of Canada (PHAC)Published: 2021
"Presentation objectives:
- To describe the features and management of delayed injection site reactions following administration of COVID-19 vaccines
- To provide an overview of the Canadian Adverse Events Following Immunization Surveillance System (CAEFISS) and the data on the Moderna and Pfizer vaccines
- To provide guidance on distinguishing these delayed injection reactions from other local reactions such as cellulitis" - COVID-19 Vaccines Emerging Issues: Delayed Injection Site Reactions
Resource Group:
Implementation Tool
Product Type: Webinar
Vaccine Safety
Adverse Events Following Immunization (AEFI)
Sub Topics: Vaccine Safety and Development
Monitoring and Surveillance
Outbreaks and Pandemics
COVID-19
Product Type: Webinar
Category:
Vaccine Safety and Development,Vaccine Safety,Adverse Events Following Immunization (AEFI),Sub Topics: Vaccine Safety and Development,Monitoring and Surveillance,Outbreaks and Pandemics,COVID-19 Vaccine Safety and DevelopmentVaccine Safety
Adverse Events Following Immunization (AEFI)
Sub Topics: Vaccine Safety and Development
Monitoring and Surveillance
Outbreaks and Pandemics
COVID-19
Language:
English
Link
AudioResource Rating Breakdown
Ratings submitted by CANVax users for this resource are tallied to provide an average resource rating per category.
0 Comments
Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.
All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.
You must login or register before you can submit a comment.